Policy and Advocacy

Hepatitis Australia provides national leadership and advocacy for action on hepatitis B and C.

We seek to ensure elimination of hepatitis B and hepatitis C by 2030 become Australia’s next major preventive and public health success.

Our policy and advocacy work improves national policies, data collection and access, and funding distribution.

Hepatitis Australia values the expertise of people affected by hepatitis B and C in all our work.

National and International Representation

Hepatitis Australia represents the interests of our members and communities in a variety of high level forums. Read more

Our submissions

Here you can view and download submissions that have been lodged by Hepatitis Australia. Read more

Policy Priorities

Hepatitis Australia's current policy priorities support the elimination of hepatitis B and hepatitis C in Australia Read more

Latest

New Research: “The most culturally safe training I’ve ever had”: the co-design of a culturally safe Managing hepatitis B training course with and for the Aboriginal health workforce of the Northern Territory of Australia

This research paper describes the factors which led to the successful co-design, delivery, and evaluation of the “Managing hepatitis B” course for the Aboriginal health workforce.
Constitutional reform is important to improve health outcomes for Aboriginal and Torres Strait Islander people and communities

In this newsletter, we highlight the positive health outcomes that can be achieved when Aboriginal and Torres Strait Islander voices are listened to. Authorised by C Fowlie, Hepatitis Australia, 4/6b Thesiger Ct, Deakin ACT 2600.
International Hepatitis B Community Forum

Hepatitis Australia is proud to be an endorser of the Hepatitis B Community Forum, occurring as part of HBV International Meeting on 19 September 2023
Aboriginal and Torres Strait Islander people advising on matters that affect them is core business of viral hepatitis elimination.

A Voice to Parliament is about Aboriginal and Torres Strait Islander people advising on matters that affect them. Authorised by C Fowlie, Hepatitis Australia, 4/6b Thesiger Ct, Deakin ACT 2600.

Eliminating Asia's Silent Emergency: White Paper Launch Webinar

Evidence-based recommendations to reduce the clinical, economic, societal and humanistic burden of Hepatitis and Hepatocellular Carcinoma and improve public health in Asia Pacific. Read more